Cargando…

Loss of heterozygosity at the ATBF1-A locus located in the 16q22 minimal region in breast cancer

BACKGROUND: Loss of heterozygosity (LOH) on the long arm of chromosome 16 is one of the most frequent genetic events in solid tumors. Recently, the AT-motif binding factor 1 (ATBF1)-A gene, which has been assigned to chromosome 16q22.3-23.1, was identified as a plausible candidate for tumor suppress...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kai, Kazuharu, Zhang, Zhenhuan, Yamashita, Hiroko, Yamamoto, Yutaka, Miura, Yutaka, Iwase, Hirotaka
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2008
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2564977/ https://www.ncbi.nlm.nih.gov/pubmed/18796146 http://dx.doi.org/10.1186/1471-2407-8-262

Ejemplares similares

ATBF1 and NQO1 as candidate targets for allelic loss at chromosome arm 16q in breast cancer: Absence of somatic ATBF1 mutations and no role for the C609T NQO1 polymorphism
por: Cleton-Jansen, Anne-Marie, et al.
Publicado: (2008)

Beta-amyloid increases the expression level of ATBF1 responsible for death in cultured cortical neurons
por: Jung, Cha-Gyun, et al.
Publicado: (2011)

Frequent Loss of Heterozygosity at the MCC Locus on Chromosome 5q21‐22 in Sporadic Colorectal Carcinomas
por: Miki, Yoshio, et al.
Publicado: (1991)

Identification of biomarkers in ductal carcinoma in situ of the breast with microinvasion
por: Okumura, Yasuhiro, et al.
Publicado: (2008)

A diagnostic marker for superficial urothelial bladder carcinoma: lack of nuclear ATBF1 (ZFHX3) by immunohistochemistry suggests malignant progression
por: Kawaguchi, Makoto, et al.
Publicado: (2016)

Loss of heterozygosity in sporadic breast tumours at the BRCA2 locus on chromosome 13q12-q13.
por: Cleton-Jansen, A. M., et al.
Publicado: (1995)

Characterization of Nuclear Localization and SUMOylation of the ATBF1 Transcription Factor in Epithelial Cells
por: Sun, Xiaodong, et al.
Publicado: (2014)

Loss of heterozygosity on chromosome 22 in ovarian carcinoma is distal to and is not accompanied by mutations in NF2 at 22q12.
por: Englefield, P., et al.
Publicado: (1994)

PTIP Associated protein 1, PA1, Is an Independent Prognostic Factor for Lymphnode Negative Breast Cancer
por: Takeshita, Takashi, et al.
Publicado: (2013)

Loss of heterozygosity occurs at the D11S29 locus on chromosome 11q23 in invasive cervical carcinoma.
por: Bethwaite, P. B., et al.
Publicado: (1995)

Coexistence of HER2 over-expression and p53 protein accumulation is a strong prognostic molecular marker in breast cancer
por: Yamashita, Hiroko, et al.
Publicado: (2004)

Loss of heterozygosity on chromosome arm 16q in breast cancer: clinical, molecular and statistical approaches
por: Cleton-Jansen, A-M, et al.
Publicado: (2000)

Evaluation of loss of heterozygosity of chromosome 22q11.21 region in patients with congenital heart diseases
por: Behiry, Eman G., et al.
Publicado: (2018)

ATBF1 Participates in Dual Functions of TGF-β via Regulation of Gene Expression and Protein Translocalization
por: Li, Mei, et al.
Publicado: (2020)

Nab-paclitaxel for the treatment of breast cancer: efficacy, safety, and approval
por: Yamamoto, Yutaka, et al.
Publicado: (2011)

The role of exosomal microRNAs; focus on clinical applications in breast cancer
por: Sueta, Aiko, et al.
Publicado: (2019)

Prevalence of ESR1 E380Q mutation in tumor tissue and plasma from Japanese breast cancer patients
por: Takeshita, Takashi, et al.
Publicado: (2017)

Inferring relationships between pairs of individuals from locus heterozygosities
por: Presciuttini, Silvano, et al.
Publicado: (2002)

Association of Loss of Heterozygosity at the p53 Locus with Chemoresistance in Osteosarcomas
por: Goto, Akiteru, et al.
Publicado: (1998)

Loss of heterozygosity on chromosome 16q increases relapse risk in Wilms’ tumor: a meta-analysis
por: Pan, Zhenyu, et al.
Publicado: (2017)

GANP protein encoded on human chromosome 21/mouse chromosome 10 is associated with resistance to mammary tumor development
por: Kuwahara, Kazuhiko, et al.
Publicado: (2016)

Loss of heterozygosity on chromosome XP22.2-p22.13 and Xq26.1-q27.1 in human breast carcinomas.
por: Choi, C., et al.
Publicado: (1998)

Loss of heterozygosity at the human leukocyte antigen locus in thymic epithelial tumors
por: Chen, Yuan, et al.
Publicado: (2015)

Identification of a Breast Cancer Susceptibility Locus at 4q31.22 Using a Genome-Wide Association Study Paradigm
por: Sapkota, Yadav, et al.
Publicado: (2013)

Mutation analysis of the Fanconi anaemia A gene in breast tumours with loss of heterozygosity at 16q24.3
por: Cleton-Jansen, A-M, et al.
Publicado: (1999)

Different Incidence of Loss of Heterozygosity on Chromosome 16q between Intraductal Papilloma and Intracystic Papillary Carcinoma of the Breast
por: Tsuda, Hitoshi, et al.
Publicado: (1994)

Atbf1 Regulates Pubertal Mammary Gland Development Likely by Inhibiting the Pro-Proliferative Function of Estrogen-ER Signaling
por: Li, Mei, et al.
Publicado: (2012)

ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer
por: Li, Mei, et al.
Publicado: (2022)

A case of synchronous bilateral breast cancer with different pathological responses to neoadjuvant chemotherapy with different biological character
por: Hayashi, Mitsuhiro, et al.
Publicado: (2013)

Randomized controlled trial of toremifene 120 mg compared with exemestane 25 mg after prior treatment with a non-steroidal aromatase inhibitor in postmenopausal women with hormone receptor-positive metastatic breast cancer
por: Yamamoto, Yutaka, et al.
Publicado: (2013)

Loss of heterozygosity on chromosome 16 in sporadic Wilms' tumour.
por: Grundy, R. G., et al.
Publicado: (1998)

p53 protein accumulation predicts resistance to endocrine therapy and decreased post-relapse survival in metastatic breast cancer
por: Yamashita, Hiroko, et al.
Publicado: (2006)

Quantitative determination, by real-time reverse transcription polymerase chain reaction, of aromatase mRNA in invasive ductal carcinoma of the breast
por: Zhang, Zhenhuan, et al.
Publicado: (2003)

Expression of the transcription factor CTCF in invasive breast cancer: a candidate gene located at 16q22.1
por: Rakha, E A, et al.
Publicado: (2004)

Loss of heterozygosity at the 5,10-methylenetetrahydrofolate reductase locus in human ovarian carcinomas.
por: Viel, A., et al.
Publicado: (1997)

Developmental Stability Covaries with Genome-Wide and Single-Locus Heterozygosity in House Sparrows
por: Vangestel, Carl, et al.
Publicado: (2011)

Loss of heterozygosity at thymidylate synthase locus in Barrett's metaplasia, dysplasia, and carcinoma sequences
por: Kuramochi, Hidekazu, et al.
Publicado: (2009)

A comprehensive analysis of Aurora A; transcript levels are the most reliable in association with proliferation and prognosis in breast cancer
por: Yamamoto, Satoko, et al.
Publicado: (2013)

Novel Nucleotide Variations, Haplotypes Structure and Associations with Growth Related Traits of Goat AT Motif-Binding Factor (ATBF1) Gene
por: Zhang, Xiaoyan, et al.
Publicado: (2015)

Glucose-dependent insulinotropic peptide receptor overexpression in adrenocortical hyperplasia in MEN1 syndrome without loss of heterozygosity at the 11q13 locus
por: Costa, Marcia Helena Soares, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_5bg4ur7qimo3qk1d0fvste1r33